Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cardinal Health, Inc. (CAH : NYSE)
 
 • Company Description   
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?

Number of Employees: 48,900

 
 • Price / Volume Information   
Yesterday's Closing Price: $161.98 Daily Weekly Monthly
20 Day Moving Average: 2,473,371 shares
Shares Outstanding: 238.68 (millions)
Market Capitalization: $38,660.90 (millions)
Beta: 0.68
52 Week High: $168.44
52 Week Low: $93.17
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.13% 0.80%
12 Week 24.17% 8.81%
Year To Date 36.96% 29.35%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
7000 CARDINAL PLACE
-
DUBLIN,OH 43017
USA
ph: 614-757-5000
fax: 614-757-6000
investor.relations@cardinalhealth.com http://www.cardinalhealth.com
 
 • General Corporate Information   
Officers
Jason M. Hollar - Chief Executive Officer and Director
Aaron E. Alt - Chief Financial Officer
Mary C. Scherer - Senior Vice President and Chief Accounting Officer
Robert W. Azelby - Director
Steven K. Barg - Director

Peer Information
Cardinal Health, Inc. (ITRJ)
Cardinal Health, Inc. (BRLI.)
Cardinal Health, Inc. (GOGY)
Cardinal Health, Inc. (PSTX.)
Cardinal Health, Inc. (ELGXQ)
Cardinal Health, Inc. (CAH)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED/DENTAL-SUPP
Sector: Medical
CUSIP: 14149Y108
SIC: 5122
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 238.68
Most Recent Split Date: 4.00 (1.50:1)
Beta: 0.68
Market Capitalization: $38,660.90 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 1.26%
Current Fiscal Quarter EPS Consensus Estimate: $2.18 Indicated Annual Dividend: $2.04
Current Fiscal Year EPS Consensus Estimate: $9.24 Payout Ratio: 0.25
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: -0.08
Estmated Long-Term EPS Growth Rate: 10.93% Last Dividend Paid: 04/01/2025 - $0.51
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 17.53
Trailing 12 Months: 20.25
PEG Ratio: 1.60
Price Ratios
Price/Book: -
Price/Cash Flow: 15.38
Price / Sales: 0.17
EPS Growth
vs. Year Ago Period: 12.98%
vs. Previous Quarter: 21.76%
Sales Growth
vs. Year Ago Period: -0.06%
vs. Previous Quarter: -0.70%
ROE
06/30/25 - -
03/31/25 - -68.84
12/31/24 - -59.57
ROA
06/30/25 - -
03/31/25 - 4.21
12/31/24 - 4.17
Current Ratio
06/30/25 - -
03/31/25 - 0.94
12/31/24 - 1.02
Quick Ratio
06/30/25 - -
03/31/25 - 0.50
12/31/24 - 0.54
Operating Margin
06/30/25 - -
03/31/25 - 0.88
12/31/24 - 0.85
Net Margin
06/30/25 - -
03/31/25 - 0.70
12/31/24 - 0.59
Pre-Tax Margin
06/30/25 - -
03/31/25 - 0.95
12/31/24 - 0.80
Book Value
06/30/25 - -
03/31/25 - -7.95
12/31/24 - -12.09
Inventory Turnover
06/30/25 - -
03/31/25 - 13.48
12/31/24 - 13.26
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©